Behçet's disease in Tunisia demographic, clinical and genetic aspects in 260 patients

Clinical and Experimental Rheumatology

Volumn 25, Issue 4 SUPPL. 45, 2007, Pages

  Houman, Mohamed Habib ^a,b   Neffati, Hajer ^a,b   Braham, Amel ^a   Harzallah, Olfa ^a   Khanfir, Monia ^a,b   Miled, Mohamed ^a   Hamzaoui, Kamel ^b  

^a LA RABTA HOSPITAL   (Tunisia)

^b UNIVERSITY OF TUNIS EL MANAR   (Tunisia)

Author keywords

Beh et's syndrome; Epidemiology; Neurologic manifestations; Thrombosis; Tunisia; Uveitis; Vasculitis

Indexed keywords

ACENOCOUMAROL; ANTICOAGULANT AGENT; AZATHIOPRINE; COLCHICINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DAPSONE; GLUCOCORTICOID; HEPARIN; HLA B51 ANTIGEN; IMMUNOSUPPRESSIVE AGENT; LOW MOLECULAR WEIGHT HEPARIN; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISONE;

ADOLESCENT; ADULT; ARTHRITIS; ARTICLE; BEHCET DISEASE; CENTRAL NERVOUS SYSTEM DISEASE; CEREBROVASCULAR DISEASE; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DRUG MEGADOSE; ETHNIC DIFFERENCE; EYE DISEASE; FEMALE; GASTROINTESTINAL DISEASE; GENITAL ULCER; GEOGRAPHIC DISTRIBUTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MOUTH ULCER; NEUROLOGIC DISEASE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEX DIFFERENCE; TUNISIA; UNIVERSITY HOSPITAL; VEIN THROMBOSIS; COHORT ANALYSIS; DEMOGRAPHY; DIGESTIVE SYSTEM INJURY; ERYTHEMA NODOSUM; ETHNIC GROUP; FOLLICULITIS; HEREDITY; MORBIDITY; ONSET AGE; PRESCHOOL CHILD; SCHOOL CHILD;

ADOLESCENT; ADULT; ARTHRITIS; BEHCET SYNDROME; CHILD; COHORT STUDIES; FEMALE; HLA-B ANTIGENS; HOSPITALS, UNIVERSITY; HUMANS; MALE; MIDDLE AGED; ORAL ULCER; RETROSPECTIVE STUDIES; TUNISIA; UVEITIS; VENOUS THROMBOSIS;

EID: 35448967077     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. SAKANE T, TAKENO M, SUZUKI N, INABA G: Behçet's Disease. N Engl J Med 1999; 21: 1284-91.
2. INTERNATIONAL STUDY GROUP FOR BEHÇET'S DISEASE: Criteria for diagnosis of Behçet's disease. Lancet 1990; 335: 1078-80.
3. DILSEN N: History and development of Behçet's disease. Rev Rhum (English Ed.) 1996; 63: 512-9.
4. AZIZLERLI G, AKDAG KÖSE A, SARICA R et al.: Prevalence of Behçet's disease in Istanbul, Turkey. International Journal of Dermatology 2003, 42: 803-6.
5. YURDAKUL S, HAMURYUDAN V, YAZICI H: Behçet syndrome: Curr Op Rheum 2004, 16: 38-42.
6. BENEZRA D, FORRESTER JV, NUSSENBLATT RB, TABBARA K, TIMONEN P (Eds.): Uveitis scoring system. Berlin: Springer Verlag, 1991.
7. BUNCE M, FANNING GC, WELSH KI: Comprehensive, serologically equivalent DNA typing for HLA-B by PCR using sequence specific primers (PCR-SSP). Tissue Antigens 1995; 45: 81-90.
8. BEN AHMED M, HOUMAN H, ABDELHAK S et al.: MICA transmembrane region polymorphism and HLA B51 in Tunisian Behçet's disease patients. Adv Exp Med Biol 2003; 528: 225-8.
9. CAKIR N, DERVIS E, BENIAN O et al.: Prevalence of Behçet's disease in rural western Turkey: A preliminary report. Clin Exp Rheumatol 2004; 22: 53-5.
10. B'CHIR HAMZAOUI S, HARMEL A, BOUSLAMA K et al.: Behçet's disease in Tunisia. Clinical study of 519 cases. Rev Med Interne 2006; 27: 742-50.
11. DINC A, BAYIR A, SIMSEK I, ERDEM H, PAY S, TURAN M: The proportional Venn diagram of Behçet's disease-related manifestations among young adult men in Turkey. Clin Exp Rheumatol 2005 (Suppl. 38): S86-90.
12. ZOUBOULIS CC, KOTTER I, DJAWARI D et al.: Epidemiological features of Adamantiades-Behçet's disease in Germany and in Europe. Yonsei Med J 1997; 38: 411-22.
13. ZOUBOULIS CC: Epidemiology of Adamantiades-Behçet's disease. Ann Med Interne 1999; 150: 488-98.
14. BORLU M, UKSAL U, FERAHBAS A, EVEREKLIOGLU C: Clinical features of Behçet's disease in children. Int J Dermatol 2006; 45: 713-6.
15. TURSEN U, GURLER A, BOYVAT A: Evaluation of clinical findings according to sex in 2313 Turkish patients with Behçet's disease. Int J Dermatol 2003; 42: 346-51.
16. NAKAE K, MASAKI F, HASHIMOTO T, INABA G, MOCHIZUKI M, SAKANE T: Recent epidemiological features of Behçet's disease in Japan. In WECHSLER B, GODEAU P (Eds.) Behçet's disease. International Congress Series 1037. Amsterdam: Excerpta Medica, 1993: 145-51.
17. BANG DS, OH SH, LEE KH, LEE ES, LEE SN: Influence of sex on patients with Behçet's disease in Korea. J Korean Med Sci 2003; 18: 231-5.
18. CHENG YK, THONG BY, CHNG HH: Behçet's Disease: Experience in a tertiary rheumatology center in Singapore and a review of the literature. Ann Acad Med Singapore 2004; 33: 510-4.
19. EVEREKLIOGLU C: Current Concepts in the Etiology and Treatment of Behçet Disease. Surv Ophthalmol 2005; 50: 297-350.
20. BANG D, LEE JH, LEE ES et al.: Epidemiologic and Clinical Survey of Behçet's Disease in Korea: The First Multicenter Study. J Korean Med Sci 2001; 16: 615-8.
21. DAVATCHI F, SHAHRAM F, KUMAR A, CHENG YK, CHEONG CT, BENDRUPS A: Comparative analysis of Behçet's disease in the APLAR region. APLAR Journal of Rheumatology 2004; 7: 38-43.
22. MANGELSDORF HC, WHITE WL, JORIZZO JL: Report of twenty-five patients from the United States with prominent mucocutaneous involvement. J Am Acad Dermatol 1996; 34: 745-50.
23. BALABANOVA M, CALAMIA KT, O'DUFFY JD: A study of the cutaneous manifestations of Behçet's disease in patients from the United States. In OLIVIERI I, SALVARANI C, CANTINI F (Eds.) 8th International Congress on Behçet's Disease. Program and Abstracts. Milano: Prex, 1998: 118.
24. PIPITONE N, BOIARDI L, OLIVIERI I et al.: Clinical manifestations of Behçet's disease in 137 Italian patients: Results of a multicenter study. Clin Exp Rheumatol 2004; 22 (Suppl. 36): S46-S51.
25. KRAUSE I, UZIEL Y, GUEDJ D et al.: Mode of presentation and multisystem involvement in Behçet's disease: The influence of sex and age of disease onset. J Rheumatol 1998; 25: 1566-9.
26. BENAMOUR S, CHAOUI L, ZEROUAL B et al.: Study of 673 cases of Behçet's disease. In OLIVIERI I, SALVARANI C, CANTINI F (Eds.) 8th International Congress on Behçet's Disease. Program and Abstracts. Milano: Prex, 1998: 232.
27. AL-DALAAN AN, AL BALAA SR, EL RAMAHI K et al.: Behçet's disease in Saudi Arabia. J Rheumatol 1994; 21: 658-61.
28. ASSAAD-KHALIL S, KAMEL F, ISMAIL E: Starting a regional registry for patients with Behçet's disease in North West Nile Delta region in Egypt. In HAMZA M (Ed.) Behçet's disease. Tunis: Pub Adhoua, 1997: 173-6.
29. MADANAT W, FAYYAD F, ZUREIKAT H et al.: Analysis of 150 cases of Behçet's disease Jordan. In OLIVIERI I, SALVARANI C, CANTINI F (Eds.) 8th International Congress on Behçets Disease. Program and Abstracts. Milano: Prex, 1998: 255.
30. HAMDAN A, MANSOUR W, UTHMAN I, MASRI AF, NASR F, ARAYSSI T: Behçet's disease in Lebanon: Clinical profile, severity and two-decade comparison. Clin Rheumatol 2006; 25: 364-7.
31. ZOUBOULIS CC, VAIOPOULOS G, MARCOMICHELAKIS N et al.: Onset signs, clinical course, prognosis, treatment and outcome of adult patients with Adamantiades- Behçet's disease in Greece. Clin Exp Rheumatol 2003; 21(Suppl. 30): S19-26.
32. TUGAL-TUTKUN I, ONAL S, ALTAN-YAYCIOGLU R, HUSEYIN ALTUNBAS H, URGANCIOGLU M: Uveitis in Behçet disease: An analysis of 880 patients. Am J Ophthalmol 2004; 138: 373-80.
33. BARRA C, BELFORT JUNIOR R, ABREU MT, KIM MK, MARTINS MC, PETRILLI AM: Behçet's disease in Brazil: A review of 49 cases with emphasis on ophthalmic manifestations. Jpn J Ophthalmol 1991; 35: 339-46.
34. FILALI-ANSARY N, TAZI-MEZALEK Z, MOHATTANE A et al.: La maladie de Behçet: 162 cas. Ann Med Interne (Paris) 1999; 150: 178-88.
35. AKMAN-DEMIR G, SERDAROGLU P, TASÇI B and the NEURO-BEHÇET STUDY GROUP: Clinical patterns of neurological involvement in Behçet's disease: Evaluation of 200 patients. Brain 1999; 122: 2171-82.
36. KIDD D, STEUER A, DENMAN AM, RUDGE P: Neurological complications in Behçet's syndrome. Brain 1999; 122: 2183-94.
37. AL-ARAJI A, SHARQUIE K, AL-RAWI Z: Prevalence and patterns of neurological involvement in Behçet's disease: A prospective study from Iraq. J Neurol Neurosurg Psychiatry 2003; 74: 608-13.
38. SIVA A, ALTINTAS A, SAIP S: Behçet's syndrome and the nervous system. Curr Opin Neurol 2004; 17: 347-57.
39. DÜZGÜN N, ATES A, AYDINTUG OT, DEMIR O, ÖLMEZ O: Characteristics of vascular involvement in Behçet's disease. Scan J Rheumatol 2006; 35: 65-68.
40. GÜRLER A, BOYVAT A, TURSEN U: Clinical manifestations of Behçet's disease: An analysis of 2147 patients. Yonsei Med J 1997; 38: 423-7.
41. HOUMAN MH, BEN GHORBEL I, KHIARIBEN SALAH I, LAMLOUM M, BEN AHMED M, MILED M: Deep vein thrombosis in Behçet's disease. Clin Exp Rheumatol 2001; 19 (Suppl. 24): S48-S50.
42. HOUMAN. MH, LAMLOUM M, BEN GHORBEL I, KHIARI BEN SALAH I, MILED M: Vena cava thrombosis in Behçet's disease. Ann Med Interne 1999; 150: 587-90.
43. BAYRAKTAR Y, BALKANCI F, BAYRAKTAR M, CALGÜNARI M: Budd-Chiari syndrome: A common complication of Behçet's disease. Am J Gastroenterol 1997; 92: 858-62.
44. CALAMIA KT, SCHIRMER M, MELIKOGLU M: Major vessel involvement in Behçet disease. Curr Opin Rheumatol 2005; 17: 1-8.
45. DINC A, TAKAFUTA T, JIANG D, MELIKOGLU M, SARUHAN-DIRESKENELI G, SHAPIRO SS: Anti-endothelial cell antibodies in Behçet's disease. Clin Exp Rheumatol 2003; 21: S27-S30.
46. KRAUSE I, WEINBERGER A: Vasculo-Behçet's disease. Isr Med Assoc J 2002; 4: 636-7.
47. YAZICI H, FRESKODI, YURDAKUL S: Behçet's syndrome: disease manifestations, management, and advances in treatment. Nat Clin Pract Rheumatol 2007; 3: 148-55.